Your session is about to expire
← Back to Search
HPV Vaccination Strategy for Increasing Uptake
N/A
Waitlist Available
Led By Jane Garbutt, MB, ChB
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights
Study Summary
This trial will test a strategy to increase HPV vaccination rates in primary care practices.
Who is the study for?
This trial is for community-based pediatric primary care practices with at least two providers who offer wellness care to preteens and adolescents. Participants must be willing to engage in a quality improvement process guided by a practice facilitator and complete study questionnaires.Check my eligibility
What is being tested?
The trial is testing whether a combination of strategies including audit and feedback, communication tactics, practice facilitation, and education can increase the use of HPV vaccines in primary care settings.See study design
What are the potential side effects?
Since this trial focuses on implementation strategies rather than medical treatments, it does not directly involve side effects related to drugs or vaccines. However, there may be indirect impacts on practice workflow or patient-provider interactions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Completion of the HPV Vaccine 2-dose Series.
Initiation of the HPV Vaccine 2-dose Series.
Secondary outcome measures
Sustainability of the Intervention Benefit for Completion of the HPV Vaccine.
Sustainability of the Intervention Benefit for Initiation of the HPV Vaccine.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment4 Interventions
Practices randomly assigned to this arm will receive the multi-component intervention.
Group II: Wait list control groupActive Control1 Intervention
Practices randomly assigned to this arm will be placed on a waiting list to receive the intervention in the last two years of the study.
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,931 Previous Clinical Trials
2,299,689 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,647 Total Patients Enrolled
Jane Garbutt, MB, ChBPrincipal InvestigatorWashington University School of Medicine
2 Previous Clinical Trials
190 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- The study is looking for healthcare providers who provide care to children and teenagers.I am willing to fill out study questionnaires.You agree to take part in a program with a guide who will help you make improvements in your healthcare.My practice serves children, has 2 or more providers, and is community-based.
Research Study Groups:
This trial has the following groups:- Group 1: Wait list control group
- Group 2: Intervention Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is sign-up for this research currently available?
"Data hosted on clinicaltrials.gov implies that this trial is no longer searching for participants, as the study was last updated in September 2022. Although recruitment has ceased, there are four different trials actively enrolling patients at present time."
Answered by AI
Popular Categories
Share this study with friends
Copy Link
Messenger